ClinicalTrials.Veeva

Menu

Vascular Function in Adolescent, Diabetic Children

Children's Mercy Hospital Kansas City logo

Children's Mercy Hospital Kansas City

Status

Completed

Conditions

Type 1 Diabetes

Treatments

Procedure: Measurement of vascular function per SphymgnoCor equipment

Study type

Interventional

Funder types

Other

Identifiers

NCT00348179
04 04-036E

Details and patient eligibility

About

The objectives of this investigator initiated study are to:

  1. Determine if and when vascular abnormalities occur during early adolescence
  2. Determine if poor diabetic control is related to vascular abnormalities.

The development of vascular plaques and vascular contractility will be assessed through the use of the SyphmgnoCor equipment.

Full description

Up to 85 Type 1 diabetic and healthy controls, 12-14 years of age, will be recruited for the study. Once the Permission/Assent form has been completed, a cuff will be applied to the arm and the pressure tonometer will be used on various vessels. Cardiovascular data will be recorded. The procedure is non-invasive, will last approximately 10 minutes and will be performed during a routine clinic visit. Onset of diabetes and level of diabetic control as measured by the most recent Hbg A1c (relative to the study visit) will be obtained from the medical record. Microalbumin levels covering the prior 12 months will be collected from the medical record of diabetic subjects.

Enrollment

85 patients

Sex

All

Ages

12 to 14 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Boys and girls ages 12-14 years who have Type 1 diabetes or are healthy controls

Exclusion criteria

  • Children and adolescents who do not meet inclusion criteria

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems